Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 4
2007 4
2009 1
2011 1
2012 2
2013 5
2014 1
2015 1
2016 1
2017 2
2018 1
2020 1
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Targeting Oncoimmune Drivers of Cancer Metastasis.
Kudo-Saito C, Ozaki Y, Imazeki H, Hayashi H, Masuda J, Ozawa H, Ogiwara Y. Kudo-Saito C, et al. Cancers (Basel). 2021 Feb 1;13(3):554. doi: 10.3390/cancers13030554. Cancers (Basel). 2021. PMID: 33535613 Free PMC article. Review.
Costimulatory molecules as adjuvants for immunotherapy.
Hodge JW, Greiner JW, Tsang KY, Sabzevari H, Kudo-Saito C, Grosenbach DW, Gulley JL, Arlen PM, Marshall JL, Panicali D, Schlom J. Hodge JW, et al. Among authors: kudo saito c. Front Biosci. 2006 Jan 1;11:788-803. doi: 10.2741/1837. Front Biosci. 2006. PMID: 16146771 Review.
The mechanisms of cancer immunoescape and development of overcoming strategies.
Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, Iwata-Kajihara T, Nishio H, Kawamura N, Kawakami Y. Yaguchi T, et al. Among authors: kudo saito c. Int J Hematol. 2011 Mar;93(3):294-300. doi: 10.1007/s12185-011-0799-6. Epub 2011 Mar 5. Int J Hematol. 2011. PMID: 21374075 Review.
Blocking the FSTL1-DIP2A Axis Improves Anti-tumor Immunity.
Kudo-Saito C, Ishida A, Shouya Y, Teramoto K, Igarashi T, Kon R, Saito K, Awada C, Ogiwara Y, Toyoura M. Kudo-Saito C, et al. Cell Rep. 2018 Aug 14;24(7):1790-1801. doi: 10.1016/j.celrep.2018.07.043. Cell Rep. 2018. PMID: 30110636 Free article.
TRICOM vector based cancer vaccines.
Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, Chakraborty M, Gulley JL, Arlen PM, Schlom J, Hodge JW. Garnett CT, et al. Among authors: kudo saito c. Curr Pharm Des. 2006;12(3):351-61. doi: 10.2174/138161206775201929. Curr Pharm Des. 2006. PMID: 16454749 Review.
Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C. Ogiwara Y, et al. Among authors: kudo saito c. Cancer Lett. 2022 Jul 1;537:215690. doi: 10.1016/j.canlet.2022.215690. Epub 2022 Apr 16. Cancer Lett. 2022. PMID: 35439537
IL33 Is a Key Driver of Treatment Resistance of Cancer.
Kudo-Saito C, Miyamoto T, Imazeki H, Shoji H, Aoki K, Boku N. Kudo-Saito C, et al. Cancer Res. 2020 May 15;80(10):1981-1990. doi: 10.1158/0008-5472.CAN-19-2235. Epub 2020 Mar 10. Cancer Res. 2020. PMID: 32156776
36 results